300 related articles for article (PubMed ID: 37898981)
1. Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review.
Sheng M; Zhang Y; Wang Y; Liu W; Wang X; Ke T; Liu P; Wang S; Shao W
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17691-17708. PubMed ID: 37898981
[TBL] [Abstract][Full Text] [Related]
2. Aberrant regulation of alternative pre-mRNA splicing in hepatocellular carcinoma.
Liu L; Xie S; Zhang C; Zhu F
Crit Rev Eukaryot Gene Expr; 2014; 24(2):133-49. PubMed ID: 24940767
[TBL] [Abstract][Full Text] [Related]
3. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
[TBL] [Abstract][Full Text] [Related]
4. RNA splicing: a dual-edged sword for hepatocellular carcinoma.
Kashyap A; Tripathi G; Tripathi A; Rao R; Kashyap M; Bhat A; Kumar D; Rajhans A; Kumar P; Chandrashekar DS; Mahmood R; Husain A; Zayed H; Bharti AC; Kashyap MK
Med Oncol; 2022 Aug; 39(11):173. PubMed ID: 35972700
[TBL] [Abstract][Full Text] [Related]
5. Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.
Chen H; Gao F; He M; Ding XF; Wong AM; Sze SC; Yu AC; Sun T; Chan AW; Wang X; Wong N
Hepatology; 2019 Sep; 70(3):1011-1025. PubMed ID: 30637779
[TBL] [Abstract][Full Text] [Related]
6. A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines.
Toki Y; Sasaki K; Tanaka H; Yamamoto M; Hatayama M; Ito S; Ikuta K; Shindo M; Hasebe T; Nakajima S; Sawada K; Fujiya M; Torimoto Y; Ohtake T; Kohgo Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):501-507. PubMed ID: 27264950
[TBL] [Abstract][Full Text] [Related]
7. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Arp5 expression by alternative splicing coupled to nonsense-mediated RNA decay.
Morita T; Hayashi K
Biochem Biophys Res Commun; 2023 May; 657():50-58. PubMed ID: 36977368
[TBL] [Abstract][Full Text] [Related]
9. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
10. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
11. Unproductive alternative splicing and nonsense mRNAs: a widespread phenomenon among plant circadian clock genes.
Filichkin SA; Mockler TC
Biol Direct; 2012 Jul; 7():20. PubMed ID: 22747664
[TBL] [Abstract][Full Text] [Related]
12. Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression.
Yan Q; Fang X; Liu X; Guo S; Chen S; Luo M; Lan P; Guan XY
Adv Sci (Weinh); 2024 Jan; 11(1):e2305653. PubMed ID: 37985644
[TBL] [Abstract][Full Text] [Related]
13. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.
Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
[TBL] [Abstract][Full Text] [Related]
15. Negative selection pressure against premature protein truncation is reduced by alternative splicing and diploidy.
Xing Y; Lee CJ
Trends Genet; 2004 Oct; 20(10):472-5. PubMed ID: 15363899
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans.
Lewis BP; Green RE; Brenner SE
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):189-92. PubMed ID: 12502788
[TBL] [Abstract][Full Text] [Related]
17. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
[TBL] [Abstract][Full Text] [Related]
18. Perspective in Alternative Splicing Coupled to Nonsense-Mediated mRNA Decay.
García-Moreno JF; Romão L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321981
[TBL] [Abstract][Full Text] [Related]
19. Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
Oka M; Xu L; Suzuki T; Yoshikawa T; Sakamoto H; Uemura H; Yoshizawa AC; Suzuki Y; Nakatsura T; Ishihama Y; Suzuki A; Seki M
Genome Biol; 2021 Jan; 22(1):9. PubMed ID: 33397462
[TBL] [Abstract][Full Text] [Related]
20. Alternative Splicing in Hepatocellular Carcinoma.
Lee SE; Alcedo KP; Kim HJ; Snider NT
Cell Mol Gastroenterol Hepatol; 2020; 10(4):699-712. PubMed ID: 32389640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
